American Gastroenterological Association Institute Guideline on the Use of Thiopurines, Methotrexate, and Anti–TNF-α Biologic Drugs for the Induction and Maintenance of Remission in Inflammatory Crohn's Disease-Reference-Cited by-同舟云学术

American Gastroenterological Association Institute Guideline on the Use of Thiopurines, Methotrexate, and Anti–TNF-α Biologic Drugs for the Induction and Maintenance of Remission in Inflammatory Crohn's Disease

Published:2013-12 Issue:6 Volume:145 Page:1459-1463
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Terdiman Jonathan P.,Gruss Claudia B.,Heidelbaugh Joel J.,Sultan Shahnaz,Falck–Ytter Yngve T.

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference2 articles.

1. The AGA Institute process for developing clinical practice guidelines part one: grading the evidence;Sultan;Clin Gastroenterol Hepatol,2013

2. American Gastroenterological Association technical review on the use of thiopurines, methotrexate, and anti–TNF-α biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease;Dassopoulos;Gastroenterology,2013

Cited by 200 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An in situ bioadhesive foam as a large intestinal delivery platform for antibody fragment to treat inflammatory bowel disease;Journal of Controlled Release;2024-10

2. Controversies in the management of anti-TNF therapy in patients with Crohn’s disease: a Delphi consensus;BMJ Open Gastroenterology;2024-01

3. Knowledge, attitude, and practice of patients living with inflammatory bowel disease: A cross-sectional study;World Journal of Gastroenterology;2023-11-21

4. A retrospective analysis of treatment patterns, drug discontinuation and healthcare costs in Crohn's disease patients treated with biologics;Digestive and Liver Disease;2023-09

5. Complementary and alternative medicine mention and recommendations in inflammatory bowel disease guidelines: systematic review and assessment using AGREE II;BMC Complementary Medicine and Therapies;2023-07-11